When symptom relief is consistent, each day has possibilities*

*For patients with COPD who seek symptom relief, YUPELRI is the first and only once-daily nebulized LAMA that delivers a full 24 hours of lung function improvement.1

Up to 100% of patients with Medicare Part B are covered.

J-CODE J7677

This is not a guarantee of coverage. Site of Care will determine coverage. Check with your patient’s insurance provider for coverage rules and restrictions. In certain limited instances, YUPELRI may be covered through a patient’s Medicare Part D pharmacy benefit.

YUPELRI was studied in two 12-week, randomized, double-blind, placebo-controlled, parallel-group confirmatory studies (Studies 1 and 2) to evaluate the efficacy of YUPELRI vs placebo in patients with moderate to very severe COPD. See results here.